CV Lattes
ResearcherID
ORCID
Google Scholar Citations
Universidade de São Paulo (USP). Faculdade de Ciências Farmacêuticas (FCF) (Institutional affiliation for the last research proposal) Birthplace: Brazil
Prof. Carlota Rangel Yagui is a full professor at the Department of Biochemical and Pharmaceutical Technology of the School of Pharmaceutical Sciences, University of São Paulo (USP). She has a Bachelor's Degree in Pharmacy and Biochemistry (1997) from USP and a PhD. in biochemical and Pharmaceutical Technology from the same institution (2003), with an 18 months period as a visiting student a the Massachusetts Institute of Technology (MIT-USA) from July 2001 to December 2002. She was a postdoctoral fellow at the Department of Biochemical and Pharmaceutical Technology-USP from July 2003 to May 2006. Currently, she is the Coordinator of the Graduate Program in Biochemical-Pharmaceutical Technology. She is also a member of the Brazilian Association of Pharmaceutical Sciences and the Controlled Release Society Brazilian Local Chapter. Prof. Rangel-Yagui coordinates the Laboratory of Nanobiotechnology of the University of São Paulo - Nanobio (https://www.facebook.com/nanobiolabusp/),a research group focused on nanobiotechnology, self-aggregated nanostructure, protein PEGylation and aqueous biphasic systems for protein purification. (Source: Lattes Curriculum)
| News published in Agência FAPESP Newsletter about the researcher |
| TITULO |
| Articles published in other media outlets (0 total): |
| More itemsLess items |
| VEICULO: TITULO (DATA) |
| VEICULO: TITULO (DATA) |
Cutaneous aging is a natural biologic process, however it can be accelerated by several factor such as exposition to ultraviolet (UV) A radiation. Among the factors leading to aging, one can highlight oxidative stress and the enzyme catalase is one of the endogenous mechanisms to prevent this process by reactive oxygen species neutralization. In this sense, an additional supply of catalas…
Biological medicines represent an important breakthrough of the pharmaceutical industry that generated considerable income to patent holders of the recent marketed biomolecules. Nonetheless, the need to keep competitive and to solve intrinsic problems of protein-based biodrugs, such as immunogenicity and biological instability, has led to the development of biobetters as follow-on biodrug…
Chemotherapeutic treatment of cancer with drugs such as alkylating agents, antimetabolites and antimitotics is associated to severe toxicity, damaging health cells and compromising many organs. Alkylphosphocholines (APCs), on the other hand, are a promising class of antitumor agents since they act in the cell membrane and in protein kinases inhibition. APCs prototype corresponds to Miltef…
(Only some records are available in English at this moment)
PEGylation of therapeutic proteins has been employed to improve biopharmaceuticals clinical performance (considering immunogenicity and plasma half-life). Despite the advantages of PEGylated biopharmaceuticals, the parallel reactions between reactive PEG and the functional amino acids of proteins result in heterogeneity of PEGylated species. This problem associated with the hydrolysis of …
Cancer is of the main causes of mortality in the world. Among them, acute lymphoblastic leukemia has a high incidence in children. Its treatment includes the enzyme L-asparagine, which is the focus of this project. In order to tackle problems such as high immunogenicity and low biodisponibility, Nanotechnology principles are being used to target the tumor cells improving the treatment sig…
This proposal is a sub-project of the thematic project Fapesp No 2013/086 17-7 entitled "Production of extracellular L-asparaginase: from bioprospecting to the engineering of an antileukemic biopharmaceutical" headed by Prof. Adalberto Pessoa Jr., and is included in the workplan "Nanotechnological development of L- asparaginase for pharmaceutical formulation", under the responsibility of …
(Only some records are available in English at this moment)
The present proposal is included in the context of project Fapesp 2016/16221-4, in which a research internship abroad was planned at University College London (UCL) under supervision of Prof. Giuseppe Battaglia. The focus of this project is the development of novel nanocarriers containing the enzyme L-asparaginase (ASNase). This enzyme has been used to treat acute lymphoblastic leukaemia …
Nanostructures for L-Asparaginase (ASNase) drug delivery could overcome its fast plasma clearance by encapsulating this enzyme in an internal compartment. Additionally, this strategy allows either the stealth and/or controlled release of the protein. Among different nanotechnological approaches for proteins delivery, polymersomes appear to be very promising. Polymersomes are formed throug…
| 1 / 1 | Ongoing research grants |
| 5 / 5 | Completed research grants |
| 16 / 14 | Completed scholarships in Brazil |
| 3 / 2 | Completed scholarships abroad |
| 25 / 22 | All research grants and scholarships |
| Associated processes | |